We sustain an extensive range of international research interests, supporting efforts to control globally important infectious diseases such as tuberculosis, crytpococcal meningitis and malaria.
Image courtesy of Malaria No More
International disease research
Infectious diseases are not restricted by borders and often spread rapidly worldwide. We are committed to improving diagnosis, prevention and treatment of infectious diseases worldwide.
We have strong international links and lead drug and vaccine trials and other major initiatives in Europe, Asia, Africa and South America.
Tuberculosis, cryptococcal meningitis and malaria
We have a particularly strong track record of expertise relating to tuberculosis (TB). Dr Amina Jindani runs the INTERTB network, which unites sites across the UK, Africa, Asia and South America in research and clinical trials. Other TB research focuses on new diagnostic tools and novel approaches to vaccination.
Members of our institute work in sub-Saharan Africa on the opportunistic fungal pathogen cryptococcus. Basic research, as well as clinical trials, have been highly influential in informing diagnosis and new, simpler treatment regimes.
Our researchers have contributed significantly to the fight against malaria. We have also taken part in worldwide studies for vaccine-preventable diseases such as pneumococcal infections.
Alongside our disease targeting work, we strive to develop strategies for global access and technology transfer, to ensure that our research outputs can be delivered to the most in need in low and middle- income regions.